Malaysia · Delayed Price · Currency is MYR Bioalpha Holdings Berhad Statistics
Total Valuation
KLSE:BIOHLDG has a market cap or net worth of MYR 21.10 million. The enterprise value is 9.08 million.
| Market Cap | 21.10M |
| Enterprise Value | 9.08M |
Important Dates
The last earnings date was Friday, February 27, 2026.
| Earnings Date | Feb 27, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
KLSE:BIOHLDG has 1.41 billion shares outstanding. The number of shares has increased by 11.28% in one year.
| Current Share Class | 1.41B |
| Shares Outstanding | 1.41B |
| Shares Change (YoY) | +11.28% |
| Shares Change (QoQ) | -0.00% |
| Owned by Insiders (%) | 16.13% |
| Owned by Institutions (%) | 13.89% |
| Float | 751.46M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.84 |
| PB Ratio | 0.31 |
| P/TBV Ratio | 0.55 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -0.31 |
| EV / Sales | 0.79 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -1.45 |
Financial Position
The company has a current ratio of 3.81, with a Debt / Equity ratio of 0.07.
| Current Ratio | 3.81 |
| Quick Ratio | 3.15 |
| Debt / Equity | 0.07 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.73 |
| Interest Coverage | -135.25 |
Financial Efficiency
Return on equity (ROE) is -35.97% and return on invested capital (ROIC) is -57.12%.
| Return on Equity (ROE) | -35.97% |
| Return on Assets (ROA) | -21.25% |
| Return on Invested Capital (ROIC) | -57.12% |
| Return on Capital Employed (ROCE) | -46.64% |
| Weighted Average Cost of Capital (WACC) | 10.19% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.12 |
| Inventory Turnover | 3.45 |
Taxes
| Income Tax | -4.02M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -50.00% in the last 52 weeks. The beta is 1.31, so KLSE:BIOHLDG's price volatility has been higher than the market average.
| Beta (5Y) | 1.31 |
| 52-Week Price Change | -50.00% |
| 50-Day Moving Average | 0.02 |
| 200-Day Moving Average | 0.02 |
| Relative Strength Index (RSI) | 47.98 |
| Average Volume (20 Days) | 1,125,265 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, KLSE:BIOHLDG had revenue of MYR 11.48 million and -29.65 million in losses. Loss per share was -0.02.
| Revenue | 11.48M |
| Gross Profit | -916,000 |
| Operating Income | -33.68M |
| Pretax Income | -33.89M |
| Net Income | -29.65M |
| EBITDA | -28.00M |
| EBIT | -33.68M |
| Loss Per Share | -0.02 |
Balance Sheet
The company has 18.48 million in cash and 4.59 million in debt, with a net cash position of 13.90 million or 0.01 per share.
| Cash & Cash Equivalents | 18.48M |
| Total Debt | 4.59M |
| Net Cash | 13.90M |
| Net Cash Per Share | 0.01 |
| Equity (Book Value) | 68.42M |
| Book Value Per Share | 0.05 |
| Working Capital | 19.53M |
Cash Flow
In the last 12 months, operating cash flow was -5.83 million and capital expenditures -433,000, giving a free cash flow of -6.26 million.
| Operating Cash Flow | -5.83M |
| Capital Expenditures | -433,000 |
| Depreciation & Amortization | 5.67M |
| Net Borrowing | -783,000 |
| Free Cash Flow | -6.26M |
| FCF Per Share | -0.00 |
Margins
Gross margin is -7.98%, with operating and profit margins of -293.29% and -258.23%.
| Gross Margin | -7.98% |
| Operating Margin | -293.29% |
| Pretax Margin | -295.17% |
| Profit Margin | -258.23% |
| EBITDA Margin | -243.87% |
| EBIT Margin | -293.29% |
| FCF Margin | n/a |
Dividends & Yields
KLSE:BIOHLDG does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -11.28% |
| Shareholder Yield | -11.28% |
| Earnings Yield | -140.55% |
| FCF Yield | -29.68% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on December 6, 2016. It was a forward split with a ratio of 1.0117668484.
| Last Split Date | Dec 6, 2016 |
| Split Type | Forward |
| Split Ratio | 1.0117668484 |
Scores
KLSE:BIOHLDG has an Altman Z-Score of 0.78 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.78 |
| Piotroski F-Score | 3 |